The case for universal hepatitis B birth dose vaccine in SA

Health experts are urging South African policymakers to adopt a universal hepatitis B birth dose vaccine to help meet global elimination targets. Currently, South Africa uses a selective approach, which researchers argue is insufficient to prevent mother-to-child transmission.
Why it matters
Universal vaccination is considered a cost-effective and essential strategy for reducing the high burden of viral hepatitis in sub-Saharan Africa.
For years, concerned health experts have been calling for South African children to be universally vaccinated against hepatitis B at birth: now, echoing that plea in The Lancet , Mariet Benade and Allison Portnoy urge policy-makers to accelerate the implementation, saying it would be a crucial, and economically viable step towards the ultimate goal of eliminating the disease.
In 2016, the WHO outlined targets to eliminate viral hepatitis, aiming for a 90% reduction in incident cases and 65% reduction in mortality by 2030 . Sub-Saharan Africa accounts for 60% of the global burden of viral hepatitis.
Vaccination has been a key strategy in achieving the set targets, with the WHO recommending administration of a hepatitis B birth dose (HepB-BD) to all newborns within 24 hours of birth to prevent mother-to-child transmission, given that mother-to-child transmission is the predominant route of infection in settings with sustained transmission.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in